The study is a Phase 1 clinical trial of the study drug EIDD-2801 in participants with COVID-19

Study number SP0311 RECRUITMENT CURRENTLY ON HOLD
Group People who have had symptoms of COVID-19 within the last 5 days
Gender Male / Female
Age 18 +
Location Liverpool
Compensation Reimbursement of £30 per visit, plus travel expenses
Recruiting from Oct 2020
Additional details 1 screening visit and 8 outpatient visits over a 29 day period